Report banner
Home
Industries
Healthcare
IVD in Cardiology and Neurology Market
Updated On

Jan 16 2025

Total Pages

176

Market
Insights

7,500+

Reports delivered globally, covering a wide range of industries and sectors.

2,350+

Clients who trust our expertise and rely on our insights for business decisions.

1,050+

Managed Reports, ensuring seamless updates and premium service.

100%

Satisfied Customers, committed to delivering exceptional value and quality.

IVD in Cardiology and Neurology Market Report Probes the 15.6 Billion Size, Share, Growth Report and Future Analysis by 2033

IVD in Cardiology and Neurology Market by Product Type (Instruments, Reagents, kits, & consumables, Software & services), by Technology (Immunoassays, Molecular diagnostics, Hematology, Other technologies), by End-use (Hospitals & clinics, Diagnostic laboratories, Other end-users), by North America (U.S., Canada), by Europe (Germany, UK, France, Spain, Italy, Rest of Europe), by Asia Pacific (Japan, China, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Argentina, Rest of Latin America), by Middle East and Africa (Saudi Arabia, South Africa, UAE, Rest of Middle East and Africa) Forecast 2025-2033

Main Logo

IVD in Cardiology and Neurology Market Report Probes the 15.6 Billion Size, Share, Growth Report and Future Analysis by 2033

Key Insights

The size of the IVD in Cardiology and Neurology market was valued at USD XXX Billion in 2023 and is projected to reach USD XXX Billion by 2032, with an expected CAGR of 5% during the forecast period.IVD in cardiology and neurology involves the in vitro diagnostic tests performed to detect and diagnose diseases and conditions related to the cardiovascular system and the nervous system. It is conducted outside the body by examining samples of blood, tissue, or other body fluids.IVD tests play an important role in the diagnosis and management of cardiovascular diseases such as heart attack, stroke, and atherosclerosis. Other diagnoses and follow-ups of neurological disorders include Alzheimer's disease, Parkinson's disease, and multiple sclerosis.The IVD in the markets of cardiology and neurology is growing owing to increased cases of cardiovascular and neurological diseases, new technologies in clinical diagnostics, and enhanced funding into research and development of novel diagnostic tests.

IVD in Cardiology and Neurology Market Research Report - Market Size, Growth & Forecast

IVD in Cardiology and Neurology Market Concentration & Characteristics

The IVD in Cardiology and Neurology Market exhibits a moderate level of concentration, with leading players holding a significant market share. Innovation has emerged as a defining characteristic of this market, driven by ongoing research and development efforts. Regulatory requirements and standards play a crucial role in ensuring the accuracy and reliability of diagnostic tests, shaping the overall market landscape. Product substitutes, such as alternative diagnostic methods, can impact market dynamics, leading to competition and the adoption of new technologies. End-user concentration is evident, with hospitals and clinics accounting for a substantial portion of the market. The level of mergers and acquisitions (M&A) in this market has been moderate, with strategic collaborations and partnerships emerging as common strategies for growth and expansion.

IVD in Cardiology and Neurology Market Trends

The IVD in Cardiology and Neurology Market is poised for continued growth, driven by several key trends:

  • Advancements in Molecular Diagnostics: Technological advancements in molecular diagnostics, such as PCR and next-generation sequencing (NGS), have revolutionized the diagnosis of cardiovascular and neurological diseases, leading to more accurate and personalized treatments.
  • Rising Prevalence of Cardiovascular and Neurological Diseases: The increasing incidence of cardiovascular and neurological diseases, particularly in aging populations, has fueled the demand for IVD tests for early detection and disease management.
  • Growing Focus on Personalized Medicine: The shift towards personalized medicine has created a need for customized diagnostic solutions that cater to individual patient profiles and treatment plans, driving growth in the IVD market.
  • Technological Innovations in Instrumentation: Innovations in instrumentation, such as miniaturization, automation, and point-of-care testing, have enhanced the efficiency, accessibility, and affordability of IVD tests.
  • Increasing Healthcare Expenditure: Rising healthcare expenditure in both developed and developing countries has contributed to the growth of the IVD market, supporting investments in diagnostic technologies and infrastructure.

IVD in Cardiology and Neurology Market Growth

Key Region or Country & Segment to Dominate the Market

Key Regions Dominating the Market:

  • North America
  • Europe
  • Asia Pacific

Leading Segments Dominating the Market:

  • Product Type: Reagents, kits, & consumables
  • Technology: Immunoassays

IVD in Cardiology and Neurology Market Product Insights Report Coverage & Deliverables

The IVD in Cardiology and Neurology Market Product Insights Report provides comprehensive coverage of the market, including:

  • Market Sizing & Segmentation: Detailed analysis of market size and growth prospects across various segments, including product type, technology, and end-use.
  • Competitive Landscape: In-depth profiles of leading players, including market share analysis, product portfolios, and growth strategies.
  • Emerging Trends: Identification of key trends shaping the market, such as technological advancements, regulatory changes, and industry collaborations.
  • Future Outlook: Projections of market growth, emerging opportunities, and challenges for the future.

IVD in Cardiology and Neurology Market Analysis

The IVD in Cardiology and Neurology Market has witnessed significant growth in recent years, with a market size estimated at USD 15.6 Billion. The market is expected to maintain its growth trajectory, reaching a projected valuation of USD 23.9 Billion by 2027. North America currently dominates the market, followed by Europe and Asia Pacific. The market is driven by the rising prevalence of cardiovascular and neurological diseases, technological advancements, and increasing healthcare expenditure. Key players in the market include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

IVD in Cardiology and Neurology Market Regional Insights

  • North America: The largest regional market, driven by well-established healthcare infrastructure, high prevalence of cardiovascular and neurological diseases, and favorable reimbursement policies.
  • Europe: A major market with strong growth potential, supported by advanced healthcare systems and government initiatives to promote early diagnosis and treatment.
  • Asia Pacific: A rapidly growing market, driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and government investments in healthcare infrastructure.
  • Rest of World: This region includes Latin America, the Middle East, and Africa, and offers significant growth opportunities due to expanding healthcare access and improving economic conditions.

Driving Forces: What's Propelling the IVD in Cardiology and Neurology Market

  • Increasing Prevalence of Cardiovascular and Neurological Diseases
  • Technological Advancements in Diagnostics
  • Rising Demand for Personalized Medicine
  • Growing Healthcare Expenditure
  • Supportive Government Initiatives

Challenges and Restraints in IVD in Cardiology and Neurology Market

  • Stringent Regulatory Requirements
  • High Cost of IVD Tests
  • Lack of Skilled Professionals
  • Reimbursement Challenges

Emerging Trends in IVD in Cardiology and Neurology Market

  • Advancements in Molecular Diagnostics
  • Telemedicine and Remote Testing
  • Artificial Intelligence in Diagnostics
  • Point-of-Care Testing
  • Companion Diagnostics

IVD in Cardiology and Neurology Industry News

  • March 2023: Abbott obtained U.S. FDA clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test.
  • March 2022: BD collaborated with Babson Diagnostics for a strategic partnership to move blood sample collection into new care settings.

Leading Players in the IVD in Cardiology and Neurology Market

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

IVD in Cardiology and Neurology Market Segmentation

1. Product Type

  • 1.1. Instruments
  • 1.2. Reagents, kits, & consumables
  • 1.3. Software & services

2. Technology

  • 2.1. Immunoassays
    • 2.1.1. Enzyme-linked immunosorbent assay (ELISA)
    • 2.1.2. Chemiluminescence immunoassay (CLIA)
    • 2.1.3. Fluorescence immunoassay (FIA)
    • 2.1.4. Other immunoassays
  • 2.2. Molecular diagnostics
    • 2.2.1. Polymerase chain reaction (PCR)
    • 2.2.2. Hybridization
    • 2.2.3. Sequencing
    • 2.2.4. Isothermal nucleic acid amplification technology (INAAT)
    • 2.2.5. Microarrays
    • 2.2.6. Other molecular diagnostics
  • 2.3. Hematology
  • 2.4. Other technologies

3. End-use

  • 3.1. Hospitals & clinics
  • 3.2. Diagnostic laboratories
  • 3.3. Other end-users

IVD in Cardiology and Neurology Market Segmentation By Geography

1. North America

  • 1.1. U.S.
  • 1.2. Canada

2. Europe

  • 2.1. Germany
  • 2.2. UK
  • 2.3. France
  • 2.4. Spain
  • 2.5. Italy
  • 2.6. Rest of Europe

3. Asia Pacific

  • 3.1. Japan
  • 3.2. China
  • 3.3. India
  • 3.4. Australia
  • 3.5. South Korea
  • 3.6. Rest of Asia Pacific

4. Latin America

  • 4.1. Brazil
  • 4.2. Mexico
  • 4.3. Argentina
  • 4.4. Rest of Latin America

5. Middle East and Africa

  • 5.1. Saudi Arabia
  • 5.2. South Africa
  • 5.3. UAE
  • 5.4. Rest of Middle East and Africa

IVD in Cardiology and Neurology Market Regional Share

IVD in Cardiology and Neurology Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2019-2033
Base Year 2024
Estimated Year 2025
Forecast Period2025-2033
Historical Period2019-2024
Growth RateCAGR of 5% from 2019-2033
Segmentation
    • By Product Type
      • Instruments
      • Reagents, kits, & consumables
      • Software & services
    • By Technology
      • Immunoassays
        • Enzyme-linked immunosorbent assay (ELISA)
        • Chemiluminescence immunoassay (CLIA)
        • Fluorescence immunoassay (FIA)
        • Other immunoassays
      • Molecular diagnostics
        • Polymerase chain reaction (PCR)
        • Hybridization
        • Sequencing
        • Isothermal nucleic acid amplification technology (INAAT)
        • Microarrays
        • Other molecular diagnostics
      • Hematology
      • Other technologies
    • By End-use
      • Hospitals & clinics
      • Diagnostic laboratories
      • Other end-users
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • UAE
      • Rest of Middle East and Africa
Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1 Growing prevalence of cardiovascular and neurological disorders
        • 3.2.2 Technological advancements in IVD diagnostics
        • 3.2.3 Rising adoption of point of care testing
        • 3.2.4 Increasing focus on research for the development of novel diagnostics
      • 3.3. Market Restrains
        • 3.3.1 Stringent regulatory scenario
        • 3.3.2 High development costs
      • 3.4. Market Trends
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global IVD in Cardiology and Neurology Market Analysis, Insights and Forecast, 2019-2031
    • 5.1. Market Analysis, Insights and Forecast - by Product Type
      • 5.1.1. Instruments
      • 5.1.2. Reagents, kits, & consumables
      • 5.1.3. Software & services
    • 5.2. Market Analysis, Insights and Forecast - by Technology
      • 5.2.1. Immunoassays
        • 5.2.1.1. Enzyme-linked immunosorbent assay (ELISA)
        • 5.2.1.2. Chemiluminescence immunoassay (CLIA)
        • 5.2.1.3. Fluorescence immunoassay (FIA)
        • 5.2.1.4. Other immunoassays
      • 5.2.2. Molecular diagnostics
        • 5.2.2.1. Polymerase chain reaction (PCR)
        • 5.2.2.2. Hybridization
        • 5.2.2.3. Sequencing
        • 5.2.2.4. Isothermal nucleic acid amplification technology (INAAT)
        • 5.2.2.5. Microarrays
        • 5.2.2.6. Other molecular diagnostics
      • 5.2.3. Hematology
      • 5.2.4. Other technologies
    • 5.3. Market Analysis, Insights and Forecast - by End-use
      • 5.3.1. Hospitals & clinics
      • 5.3.2. Diagnostic laboratories
      • 5.3.3. Other end-users
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. Middle East and Africa
  6. 6. North America IVD in Cardiology and Neurology Market Analysis, Insights and Forecast, 2019-2031
    • 6.1. Market Analysis, Insights and Forecast - by Product Type
      • 6.1.1. Instruments
      • 6.1.2. Reagents, kits, & consumables
      • 6.1.3. Software & services
    • 6.2. Market Analysis, Insights and Forecast - by Technology
      • 6.2.1. Immunoassays
        • 6.2.1.1. Enzyme-linked immunosorbent assay (ELISA)
        • 6.2.1.2. Chemiluminescence immunoassay (CLIA)
        • 6.2.1.3. Fluorescence immunoassay (FIA)
        • 6.2.1.4. Other immunoassays
      • 6.2.2. Molecular diagnostics
        • 6.2.2.1. Polymerase chain reaction (PCR)
        • 6.2.2.2. Hybridization
        • 6.2.2.3. Sequencing
        • 6.2.2.4. Isothermal nucleic acid amplification technology (INAAT)
        • 6.2.2.5. Microarrays
        • 6.2.2.6. Other molecular diagnostics
      • 6.2.3. Hematology
      • 6.2.4. Other technologies
    • 6.3. Market Analysis, Insights and Forecast - by End-use
      • 6.3.1. Hospitals & clinics
      • 6.3.2. Diagnostic laboratories
      • 6.3.3. Other end-users
  7. 7. Europe IVD in Cardiology and Neurology Market Analysis, Insights and Forecast, 2019-2031
    • 7.1. Market Analysis, Insights and Forecast - by Product Type
      • 7.1.1. Instruments
      • 7.1.2. Reagents, kits, & consumables
      • 7.1.3. Software & services
    • 7.2. Market Analysis, Insights and Forecast - by Technology
      • 7.2.1. Immunoassays
        • 7.2.1.1. Enzyme-linked immunosorbent assay (ELISA)
        • 7.2.1.2. Chemiluminescence immunoassay (CLIA)
        • 7.2.1.3. Fluorescence immunoassay (FIA)
        • 7.2.1.4. Other immunoassays
      • 7.2.2. Molecular diagnostics
        • 7.2.2.1. Polymerase chain reaction (PCR)
        • 7.2.2.2. Hybridization
        • 7.2.2.3. Sequencing
        • 7.2.2.4. Isothermal nucleic acid amplification technology (INAAT)
        • 7.2.2.5. Microarrays
        • 7.2.2.6. Other molecular diagnostics
      • 7.2.3. Hematology
      • 7.2.4. Other technologies
    • 7.3. Market Analysis, Insights and Forecast - by End-use
      • 7.3.1. Hospitals & clinics
      • 7.3.2. Diagnostic laboratories
      • 7.3.3. Other end-users
  8. 8. Asia Pacific IVD in Cardiology and Neurology Market Analysis, Insights and Forecast, 2019-2031
    • 8.1. Market Analysis, Insights and Forecast - by Product Type
      • 8.1.1. Instruments
      • 8.1.2. Reagents, kits, & consumables
      • 8.1.3. Software & services
    • 8.2. Market Analysis, Insights and Forecast - by Technology
      • 8.2.1. Immunoassays
        • 8.2.1.1. Enzyme-linked immunosorbent assay (ELISA)
        • 8.2.1.2. Chemiluminescence immunoassay (CLIA)
        • 8.2.1.3. Fluorescence immunoassay (FIA)
        • 8.2.1.4. Other immunoassays
      • 8.2.2. Molecular diagnostics
        • 8.2.2.1. Polymerase chain reaction (PCR)
        • 8.2.2.2. Hybridization
        • 8.2.2.3. Sequencing
        • 8.2.2.4. Isothermal nucleic acid amplification technology (INAAT)
        • 8.2.2.5. Microarrays
        • 8.2.2.6. Other molecular diagnostics
      • 8.2.3. Hematology
      • 8.2.4. Other technologies
    • 8.3. Market Analysis, Insights and Forecast - by End-use
      • 8.3.1. Hospitals & clinics
      • 8.3.2. Diagnostic laboratories
      • 8.3.3. Other end-users
  9. 9. Latin America IVD in Cardiology and Neurology Market Analysis, Insights and Forecast, 2019-2031
    • 9.1. Market Analysis, Insights and Forecast - by Product Type
      • 9.1.1. Instruments
      • 9.1.2. Reagents, kits, & consumables
      • 9.1.3. Software & services
    • 9.2. Market Analysis, Insights and Forecast - by Technology
      • 9.2.1. Immunoassays
        • 9.2.1.1. Enzyme-linked immunosorbent assay (ELISA)
        • 9.2.1.2. Chemiluminescence immunoassay (CLIA)
        • 9.2.1.3. Fluorescence immunoassay (FIA)
        • 9.2.1.4. Other immunoassays
      • 9.2.2. Molecular diagnostics
        • 9.2.2.1. Polymerase chain reaction (PCR)
        • 9.2.2.2. Hybridization
        • 9.2.2.3. Sequencing
        • 9.2.2.4. Isothermal nucleic acid amplification technology (INAAT)
        • 9.2.2.5. Microarrays
        • 9.2.2.6. Other molecular diagnostics
      • 9.2.3. Hematology
      • 9.2.4. Other technologies
    • 9.3. Market Analysis, Insights and Forecast - by End-use
      • 9.3.1. Hospitals & clinics
      • 9.3.2. Diagnostic laboratories
      • 9.3.3. Other end-users
  10. 10. Middle East and Africa IVD in Cardiology and Neurology Market Analysis, Insights and Forecast, 2019-2031
    • 10.1. Market Analysis, Insights and Forecast - by Product Type
      • 10.1.1. Instruments
      • 10.1.2. Reagents, kits, & consumables
      • 10.1.3. Software & services
    • 10.2. Market Analysis, Insights and Forecast - by Technology
      • 10.2.1. Immunoassays
        • 10.2.1.1. Enzyme-linked immunosorbent assay (ELISA)
        • 10.2.1.2. Chemiluminescence immunoassay (CLIA)
        • 10.2.1.3. Fluorescence immunoassay (FIA)
        • 10.2.1.4. Other immunoassays
      • 10.2.2. Molecular diagnostics
        • 10.2.2.1. Polymerase chain reaction (PCR)
        • 10.2.2.2. Hybridization
        • 10.2.2.3. Sequencing
        • 10.2.2.4. Isothermal nucleic acid amplification technology (INAAT)
        • 10.2.2.5. Microarrays
        • 10.2.2.6. Other molecular diagnostics
      • 10.2.3. Hematology
      • 10.2.4. Other technologies
    • 10.3. Market Analysis, Insights and Forecast - by End-use
      • 10.3.1. Hospitals & clinics
      • 10.3.2. Diagnostic laboratories
      • 10.3.3. Other end-users
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2024
      • 11.2. Company Profiles
        • 11.2.1 Abbott Laboratories
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Becton Dickinson and Company
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 bioMerieux S.A.
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Bio-Rad Laboratories Inc.
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Danaher Corporation
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 DiaSorin S.p.A.
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 F. Hoffmann-La Roche Ltd.
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 QIAGEN N.V.
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Siemens Healthineers AG
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 Sysmex Corporation
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
        • 11.2.11 Thermo Fisher Scientific Inc.
          • 11.2.11.1. Overview
          • 11.2.11.2. Products
          • 11.2.11.3. SWOT Analysis
          • 11.2.11.4. Recent Developments
          • 11.2.11.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global IVD in Cardiology and Neurology Market Revenue Breakdown (Billion, %) by Region 2024 & 2032
  2. Figure 2: North America IVD in Cardiology and Neurology Market Revenue (Billion), by Product Type 2024 & 2032
  3. Figure 3: North America IVD in Cardiology and Neurology Market Revenue Share (%), by Product Type 2024 & 2032
  4. Figure 4: North America IVD in Cardiology and Neurology Market Revenue (Billion), by Technology 2024 & 2032
  5. Figure 5: North America IVD in Cardiology and Neurology Market Revenue Share (%), by Technology 2024 & 2032
  6. Figure 6: North America IVD in Cardiology and Neurology Market Revenue (Billion), by End-use 2024 & 2032
  7. Figure 7: North America IVD in Cardiology and Neurology Market Revenue Share (%), by End-use 2024 & 2032
  8. Figure 8: North America IVD in Cardiology and Neurology Market Revenue (Billion), by Country 2024 & 2032
  9. Figure 9: North America IVD in Cardiology and Neurology Market Revenue Share (%), by Country 2024 & 2032
  10. Figure 10: Europe IVD in Cardiology and Neurology Market Revenue (Billion), by Product Type 2024 & 2032
  11. Figure 11: Europe IVD in Cardiology and Neurology Market Revenue Share (%), by Product Type 2024 & 2032
  12. Figure 12: Europe IVD in Cardiology and Neurology Market Revenue (Billion), by Technology 2024 & 2032
  13. Figure 13: Europe IVD in Cardiology and Neurology Market Revenue Share (%), by Technology 2024 & 2032
  14. Figure 14: Europe IVD in Cardiology and Neurology Market Revenue (Billion), by End-use 2024 & 2032
  15. Figure 15: Europe IVD in Cardiology and Neurology Market Revenue Share (%), by End-use 2024 & 2032
  16. Figure 16: Europe IVD in Cardiology and Neurology Market Revenue (Billion), by Country 2024 & 2032
  17. Figure 17: Europe IVD in Cardiology and Neurology Market Revenue Share (%), by Country 2024 & 2032
  18. Figure 18: Asia Pacific IVD in Cardiology and Neurology Market Revenue (Billion), by Product Type 2024 & 2032
  19. Figure 19: Asia Pacific IVD in Cardiology and Neurology Market Revenue Share (%), by Product Type 2024 & 2032
  20. Figure 20: Asia Pacific IVD in Cardiology and Neurology Market Revenue (Billion), by Technology 2024 & 2032
  21. Figure 21: Asia Pacific IVD in Cardiology and Neurology Market Revenue Share (%), by Technology 2024 & 2032
  22. Figure 22: Asia Pacific IVD in Cardiology and Neurology Market Revenue (Billion), by End-use 2024 & 2032
  23. Figure 23: Asia Pacific IVD in Cardiology and Neurology Market Revenue Share (%), by End-use 2024 & 2032
  24. Figure 24: Asia Pacific IVD in Cardiology and Neurology Market Revenue (Billion), by Country 2024 & 2032
  25. Figure 25: Asia Pacific IVD in Cardiology and Neurology Market Revenue Share (%), by Country 2024 & 2032
  26. Figure 26: Latin America IVD in Cardiology and Neurology Market Revenue (Billion), by Product Type 2024 & 2032
  27. Figure 27: Latin America IVD in Cardiology and Neurology Market Revenue Share (%), by Product Type 2024 & 2032
  28. Figure 28: Latin America IVD in Cardiology and Neurology Market Revenue (Billion), by Technology 2024 & 2032
  29. Figure 29: Latin America IVD in Cardiology and Neurology Market Revenue Share (%), by Technology 2024 & 2032
  30. Figure 30: Latin America IVD in Cardiology and Neurology Market Revenue (Billion), by End-use 2024 & 2032
  31. Figure 31: Latin America IVD in Cardiology and Neurology Market Revenue Share (%), by End-use 2024 & 2032
  32. Figure 32: Latin America IVD in Cardiology and Neurology Market Revenue (Billion), by Country 2024 & 2032
  33. Figure 33: Latin America IVD in Cardiology and Neurology Market Revenue Share (%), by Country 2024 & 2032
  34. Figure 34: Middle East and Africa IVD in Cardiology and Neurology Market Revenue (Billion), by Product Type 2024 & 2032
  35. Figure 35: Middle East and Africa IVD in Cardiology and Neurology Market Revenue Share (%), by Product Type 2024 & 2032
  36. Figure 36: Middle East and Africa IVD in Cardiology and Neurology Market Revenue (Billion), by Technology 2024 & 2032
  37. Figure 37: Middle East and Africa IVD in Cardiology and Neurology Market Revenue Share (%), by Technology 2024 & 2032
  38. Figure 38: Middle East and Africa IVD in Cardiology and Neurology Market Revenue (Billion), by End-use 2024 & 2032
  39. Figure 39: Middle East and Africa IVD in Cardiology and Neurology Market Revenue Share (%), by End-use 2024 & 2032
  40. Figure 40: Middle East and Africa IVD in Cardiology and Neurology Market Revenue (Billion), by Country 2024 & 2032
  41. Figure 41: Middle East and Africa IVD in Cardiology and Neurology Market Revenue Share (%), by Country 2024 & 2032
List of Tables
  1. Table 1: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Region 2019 & 2032
  2. Table 2: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Product Type 2019 & 2032
  3. Table 3: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Technology 2019 & 2032
  4. Table 4: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by End-use 2019 & 2032
  5. Table 5: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Region 2019 & 2032
  6. Table 6: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Product Type 2019 & 2032
  7. Table 7: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Technology 2019 & 2032
  8. Table 8: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by End-use 2019 & 2032
  9. Table 9: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Country 2019 & 2032
  10. Table 10: U.S. IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  11. Table 11: Canada IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  12. Table 12: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Product Type 2019 & 2032
  13. Table 13: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Technology 2019 & 2032
  14. Table 14: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by End-use 2019 & 2032
  15. Table 15: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Country 2019 & 2032
  16. Table 16: Germany IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  17. Table 17: UK IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  18. Table 18: France IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  19. Table 19: Spain IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  20. Table 20: Italy IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  21. Table 21: Rest of Europe IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  22. Table 22: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Product Type 2019 & 2032
  23. Table 23: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Technology 2019 & 2032
  24. Table 24: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by End-use 2019 & 2032
  25. Table 25: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Country 2019 & 2032
  26. Table 26: Japan IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  27. Table 27: China IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  28. Table 28: India IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  29. Table 29: Australia IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  30. Table 30: South Korea IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  31. Table 31: Rest of Asia Pacific IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  32. Table 32: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Product Type 2019 & 2032
  33. Table 33: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Technology 2019 & 2032
  34. Table 34: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by End-use 2019 & 2032
  35. Table 35: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Country 2019 & 2032
  36. Table 36: Brazil IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  37. Table 37: Mexico IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  38. Table 38: Argentina IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  39. Table 39: Rest of Latin America IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  40. Table 40: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Product Type 2019 & 2032
  41. Table 41: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Technology 2019 & 2032
  42. Table 42: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by End-use 2019 & 2032
  43. Table 43: Global IVD in Cardiology and Neurology Market Revenue Billion Forecast, by Country 2019 & 2032
  44. Table 44: Saudi Arabia IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  45. Table 45: South Africa IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  46. Table 46: UAE IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032
  47. Table 47: Rest of Middle East and Africa IVD in Cardiology and Neurology Market Revenue (Billion) Forecast, by Application 2019 & 2032

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.

Frequently Asked Questions

Get a Free Sample

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Pricing

$4,850
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
$5,350
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$8,350
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation

Looking for a Custom Report?

We offer personalized report customization at no extra cost, including the option to purchase individual sections or country-specific reports. Plus, we provide special discounts for startups and universities. Get in touch with us today!

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
avatar

Director of Business Development

Sarah L

The insights provided in this report were spot-on and exactly what we needed to guide our strategic planning. The level of detail on industry trends and forecasts is unmatched. It saved us countless hours and gave us a significant advantage!"

Discover the Latest Market Insight Reports

Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.

shop image 1

About Market Insights Report

Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.

Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.

+1 2315155523

sales@marketinsights.report

  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
sales@marketinsights.report

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

sales@marketinsights.report

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingAutomotiveHealthcareAgricultureConstructionEnergy & PowerFood & BeverageMedia & TechnologyAerospace & DefenseIndustrial MachineryChemicals & MaterialsProfessional ServicesAnimal Health & NutritionConsumer Goods and ServicesSemiconductors & Electronics

© 2025 AMA Research. All rights reserved

Testimonials
Privacy Policy
Terms and Conditions
FAQ

Related Reports

See the similar reports

report thumbnailCell Isolation Market

Cell Isolation Market Navigating Dynamics Comprehensive Analysis and Forecasts 2025-2033

report thumbnailCarboxy Therapy Market

Carboxy Therapy Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailPediatric Wheelchair Market

Pediatric Wheelchair Market Strategic Market Roadmap: Analysis and Forecasts 2025-2033

report thumbnailAutomatic Pill Dispenser Market

Automatic Pill Dispenser Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailLiposuction Devices Market

Liposuction Devices Market Charting Growth Trajectories: Analysis and Forecasts 2025-2033

report thumbnailEndomyocardial Biopsy Market

Endomyocardial Biopsy Market Insightful Market Analysis: Trends and Opportunities 2025-2033

report thumbnailGynecomastia Procedures Market

Gynecomastia Procedures Market Insightful Market Analysis: Trends and Opportunities 2025-2033

report thumbnailIntravenous (IV) Equipment Market

Intravenous (IV) Equipment Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailTendon Repair Market

Tendon Repair Market Navigating Dynamics Comprehensive Analysis and Forecasts 2025-2033

report thumbnailIntracranial Stenosis Stents Market

Intracranial Stenosis Stents Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

report thumbnailRadiofrequency Skin Rejuvenation Devices Market

Radiofrequency Skin Rejuvenation Devices Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailBiosimilars Market

Biosimilars Market Strategic Roadmap: Analysis and Forecasts 2025-2033

report thumbnailRemote Healthcare Market

Remote Healthcare Market Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

report thumbnailBlood Processing and Storage Equipment Market

Blood Processing and Storage Equipment Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailProstate Cancer Diagnostics Market

Prostate Cancer Diagnostics Market Charting Growth Trajectories 2025-2033: Strategic Insights and Forecasts

report thumbnailSolid Tumor Testing Market

Solid Tumor Testing Market 7.6 CAGR Growth Outlook 2025-2033

report thumbnailAlpha-1 Antitrypsin Deficiency Disease Treatment Market

Alpha-1 Antitrypsin Deficiency Disease Treatment Market Soars to 2.6 Billion, witnessing a CAGR of 10.1 during the forecast period 2025-2033

report thumbnailImmunomodulators Market

Immunomodulators Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

report thumbnailSurgical Navigation Systems Market

Surgical Navigation Systems Market Soars to 1.2 Billion, witnessing a CAGR of 6.7 during the forecast period 2025-2033

report thumbnailDental Implants Market

Dental Implants Market 2025-2033 Market Analysis: Trends, Dynamics, and Growth Opportunities